1.Expression of chromogranin A in human mammary tissues.
Ying-xin CHEN ; Lian-hong LI ; Jie SUN ; Bo WANG ; Li-xia WANG
Journal of Southern Medical University 2010;30(3):547-551
OBJECTIVETo explore the pathogenesis and significance of neuroendocrine breast carcinoma by detecting chromogranin A (CgA) in human mammary tissues.
METHODEighty-nine cases of human mammary tissues were collected to detect CgA expression using immunohistochemistry.
RESULTNo CgA expression was detected in normal or hyperplastic tissues, but its expression was found in mammary carcinoma tissues at the rate of 16.7%. A significant difference in CgA expression was found between cancer tissues and non-cancer tissues, but not between the cancer tissues with different pathological grades.
CONCLUSIONThe pathogenesis of mammary neuroendocrine carcinoma may involve the micro-environmental factors that affect the differentiation of stem cells to give rise to immature cells, cell differentiation in other lineages or transdifferentiation. CgA may serve as an immunological parameter for this type of breast cancer in routine screening test.
Breast ; metabolism ; Breast Neoplasms ; metabolism ; Carcinoma, Neuroendocrine ; etiology ; metabolism ; Chromogranin A ; metabolism ; Female ; Humans
3.Progress of small ubiquitin-related modifiers in kidney diseases.
Ou LI ; Qian MA ; Fei LI ; Guang-Yan CAI ; Xiang-Mei CHEN ; Quan HONG
Chinese Medical Journal 2019;132(4):466-473
OBJECTIVE:
Small ubiquitin-related modifiers (SUMOs) are a group of post-translational modification proteins extensively expressed in eukaryotes. Abnormal SUMOylation can lead to the development of various diseases. This article summarizes the progress on research of the role of SUMOs in various types of kidney diseases to further increase the understanding of the regulatory functions of SUMOylation in the pathogenesis of kidney diseases.
DATA SOURCES:
This review was based on articles published in the PubMed databases up to January 2018, using the keywords including "SUMOs," "SUMOylation," and "kidney diseases."
STUDY SELECTION:
Original articles and critical reviews about SUMOs and kidney disease were selected for this review. A total of 50 studies were in English.
RESULTS:
SUMO participates in the activation of NF-κB inflammatory signaling pathway, playing a central regulatory role in the inflammation and progression of DN, and the secretion of various chemokines in AKI. SUMO involves in the regulation of TG2 and Nrf2 antioxidant stress, affecting renal tubular injury in AKI. SUMO affects the MAPK/ERK pathway, regulating intracellular signal transduction, modulating the transcription and expression of effector molecules in DN. SUMO contributes to the TGF-β/Smad pathway, leading to fibrosis of the kidney. The conjugate combination of SUMO and p53 regulates cell proliferation and apoptosis, and participates in the regulation of tumorigenesis. In addition, SUMOylation of MITF modulates renal tumors secondary to melanoma, Similarly, SUMOylation of tumor suppressor gene VHL regulates the occurrence of renal cell carcinoma in VHL syndrome.
CONCLUSIONS
Tissue injury, inflammatory responses, fibrosis, apoptosis, and tumor proliferation in kidney diseases all involve SUMOs. Further research of the substrate SUMOylation and regulatory mechanisms of SUMO in kidney diseases will improve and develop new treatment measures and strategies targeting kidney diseases.
Acute Kidney Injury
;
etiology
;
Carcinoma, Renal Cell
;
etiology
;
Diabetic Nephropathies
;
etiology
;
Fibrosis
;
Humans
;
Kidney
;
pathology
;
Kidney Diseases
;
etiology
;
metabolism
;
Kidney Neoplasms
;
etiology
;
SUMO-1 Protein
;
physiology
;
Sumoylation
4.Lung carcinoma signaling pathways activated by smoking.
Jing WEN ; Jian-Hua FU ; Wei ZHANG ; Ming GUO
Chinese Journal of Cancer 2011;30(8):551-558
Lung cancer is the leading cause of cancer death in men and women worldwide, with over a million deaths annually. Tobacco smoke is the major etiologic risk factor for lung cancer in current or previous smokers and has been strongly related to certain types of lung cancer, such as small cell lung carcinoma and squamous cell lung carcinoma. In recent years, there has been an increased incidence of lung adenocarcinoma. This change is strongly associated with changes in smoking behavior and cigarette design. Carcinogens present in tobacco products and their intermediate metabolites can activate multiple signaling pathways that contribute to lung cancer carcinogenesis. In this review, we summarize the smoking-activated signaling pathways involved in lung cancer.
Adenocarcinoma
;
etiology
;
metabolism
;
pathology
;
Carcinoma, Squamous Cell
;
etiology
;
metabolism
;
pathology
;
Humans
;
Lung Neoplasms
;
etiology
;
metabolism
;
pathology
;
NF-kappa B
;
metabolism
;
Receptor, Epidermal Growth Factor
;
metabolism
;
Receptors, Adrenergic, beta
;
metabolism
;
Receptors, Nicotinic
;
metabolism
;
Signal Transduction
;
Small Cell Lung Carcinoma
;
etiology
;
metabolism
;
pathology
;
Smoking
;
adverse effects
;
gamma-Aminobutyric Acid
;
metabolism
5.Hepatitis C virus-induced hepatocellular carcinoma.
Nicolas GOOSSENS ; Yujin HOSHIDA
Clinical and Molecular Hepatology 2015;21(2):105-114
Hepatitis C virus (HCV) is a leading etiology of hepatocellular carcinoma (HCC). The interaction of HCV with its human host is complex and multilayered; stemming in part from the fact that HCV is a RNA virus with no ability to integrate in the host's genome. Direct and indirect mechanisms of HCV-induced HCC include activation of multiple host pathways such as liver fibrogenic pathways, cellular and survival pathways, interaction with the immune and metabolic systems. Host factors also play a major role in HCV-induced HCC as evidenced by genomic studies identifying polymorphisms in immune, metabolic, and growth signaling systems associated with increased risk of HCC. Despite highly effective direct-acting antiviral agents, the morbidity and incidence of liver-related complications of HCV, including HCC, is likely to persist in the near future. Clinical markers to selectively identify HCV subjects at higher risk of developing HCC have been reported however they require further validation, especially in subjects who have experienced sustained virological response. Molecular biomarkers allowing further refinement of HCC risk are starting to be implemented in clinical platforms, allowing objective stratification of risk and leading to individualized therapy and surveillance for HCV individuals. Another role for molecular biomarker-based stratification could be enrichment of HCC chemoprevention clinical trials leading to smaller sample size, shorter trial duration, and reduced costs.
Biomarkers, Tumor/genetics/metabolism
;
Carcinoma, Hepatocellular/*etiology
;
Hepacivirus/genetics/*pathogenicity
;
Hepatitis C/complications/pathology/virology
;
Humans
;
Liver Neoplasms/*etiology
;
Risk
6.Association between Fecal Bile Acids and Colorectal Cancer: A Meta-analysis of Observational Studies.
Jin Lu TONG ; Zhi Hua RAN ; Jun SHEN ; Guo Quan FAN ; Shu Dong XIAO
Yonsei Medical Journal 2008;49(5):792-803
PURPOSE: To provide a systematic review with meta-analysis for addressing the relationship between fecal bile acids (FBAs) and colorectal cancer. MATERIALS AND METHODS: Electronic databases were searched for all observational studies that examined the relationship between FBAs and colorectal cancer or adenoma, and calculated weighted mean difference (WMD) and 95% confidence interval (CI). Publication bias was assessed with funnel plot. RESULTS: Twenty case-control or cohort studies were identified. All studies were pooled to assess the relationship between total FBAs and cancer/adenoma of the large bowel, however, no association was seen (WMD 0.61mg/g freeze-dried feces; 95% CI: -0.35-1.57). Significantly increased concentration of chenodeoxycholic acid (CDCA) was seen while pooling to assess the relationship between CDCA and cancer/adenoma of the large bowel (WMD 0.13 mg/g freeze-dried feces; 95% CI: 0.01-0.25), especially for colorectal cancer (WMD 0.28mg/g freeze-dried feces; 95% CI: 0.10-0.46). However, no significant differences in deoxycholic acid (DCA), lithocholic acid (LCA), and primary and secondary bile acids, were seen between patients with cancer and patients with matched controls regardless of fixed and random effects models. CONCLUSION: CDCA might play a role in the etiology of colorectal cancer.
Bile Acids and Salts/*metabolism
;
Carcinoma/etiology/*metabolism
;
Case-Control Studies
;
Cohort Studies
;
Colorectal Neoplasms/etiology/*metabolism
;
Feces/*chemistry
;
Female
;
Humans
;
Male
7.Clinicopathologic features of parathyroid carcinoma: a study of 11 cases with review of literature.
Chinese Journal of Pathology 2014;43(5):296-300
OBJECTIVETo study the clinicopathologic characteristics of parathyroid carcinoma (PTC).
METHODSEleven cases of PTC encountered during the period from 1994 to 2012 were enrolled into the study. Forty cases of parathyroid adenoma (PA) were also retrieved for comparison. The clinical manifestations, laboratory results and pathologic features were analyzed, with literature review.
RESULTSThe main clinical manifestations of PTC included neck mass (11/11), hypercalcemia (11/11) and hyperparathyroidism (11/11). Most patients also had osteoporosis (10/11). In contrast, PA often manifested as hypercalcemia (40/40) and hyperparathyroidism (40/40). Histologic examination of PTC showed that the tumor cells contained clear to eosinophilic cytoplasm and separated by dense bands of fibrosis. The tumor mass was surrounded by thick fibrous capsule. Foci of capsular invasion and vascular permeation were identified at the tumor periphery in all cases. Cellular atypia was not conspicuous but mitotic figures and coagulative necrosis were easily identified. On the other hand, PA were composed of tumor cells with clear to eosinophilic cytoplasm, forming glands, trabeculae or nests. Most of them (35/40) had intact fibrous capsule. Mitotic figures were rarely encountered and tumor necrosis was absent. Immunohistochemical study showed that the tumor cells in PTC were positive for CK19 (11/11), chromogranin A (9/11), synaptophysin (7/11) and parathyroid hormone (11/11). They were negative for thyroglobulin, TTF-1 and calcitonin. The Ki-67 index was less than 10% (range = 2% to 9%). In contrast, the tumor cells in PA were positive (40/40) for CK19, chromogranin A, synaptophysin and parathyroid hormone. They were negative for thyroglobulin, TTF-1 and calcitonin. The Ki-67 index was less than 3%. Follow up-data were available in 9 cases of PTC (duration of follow up = 11 months to 224 months) and 7 of the patients were still alive. Follow up of all PA cases showed no evidence of recurrence.
CONCLUSIONSPTC is a rare malignant endocrine tumor presenting as neck mass. Histologic features suggestive of malignant behavior include presence of coagulative tumor necrosis and capsular/vascular invasion. It needs to be distinguished from other entities such as parathyroid adenoma, papillary thyroid carcinoma and medullary thyroid carcinoma.
Adenoma ; metabolism ; pathology ; Adult ; Carcinoma ; metabolism ; pathology ; Carcinoma, Neuroendocrine ; Carcinoma, Papillary ; Chromogranin A ; metabolism ; Diagnosis, Differential ; Female ; Follow-Up Studies ; Humans ; Hypercalcemia ; etiology ; Hyperparathyroidism ; etiology ; Immunohistochemistry ; Keratin-19 ; metabolism ; Male ; Middle Aged ; Osteoporosis ; etiology ; Parathyroid Hormone ; metabolism ; Parathyroid Neoplasms ; complications ; metabolism ; pathology ; surgery ; Synaptophysin ; metabolism ; Thyroid Neoplasms ; metabolism ; pathology
8.Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma.
Oh Sang KWON ; Seong Han CHOI ; Ju Hyun KIM
The Korean Journal of Gastroenterology 2015;66(6):320-324
Inflammation is one of the most prominent characteristic features of chronic liver disease, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Most of HCC cases develop in patients with cirrhosis and cirrhosis develops in patients with chronic liver inflammation. Therefore, there is no doubt that there exist some strong connection among inflammation, fibrosis, and cancer. In fact, chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC. This review will discuss the common mechanism of inflammation and fibrosis in chronic liver diseases, and then demonstrate why HCC develops in inflammatory and fibrotic conditions.
Carcinoma, Hepatocellular/*etiology
;
Gram-Negative Bacteria/growth & development
;
Hepatitis, Chronic/*complications/metabolism/microbiology
;
Humans
;
Hypoxia
;
*Inflammation
;
Lipopolysaccharides/metabolism
;
Liver/metabolism/pathology
;
Liver Cirrhosis/*complications
;
Liver Neoplasms/*etiology
;
Toll-Like Receptors/metabolism
9.Effects of MnSOD silence on in vitro tumorigenicity in NCI-H446 cells.
Qing YUAN ; Min WEN ; Xiang LI ; Ling SHU ; Jianguo CAO ; Jiansong ZHANG
Journal of Central South University(Medical Sciences) 2018;43(6):583-588
To investigate the effect of manganese superoxide dismutase (MnSOD) silence on the in vitro tumorigenicity in human small cell lung cancer NCI-H446 cells and the underlying mechanisms.
Methods: Sphere formation cells from NCI-H446 cells were obtained by suspension culture, while the expression of MnSOD and urokinase type plasminogen activator (uPAR) was analyzed by Western blot. Silence of MnSOD was performed by adenovirus infection in the second passage formation cells, and the effect of MnSOD silence on tumorigenicity in NCI-H446 cells was evaluated by sphere formation assay and soft-agar colony formation assay, while the expression of uPAR was analyzed by Western blot.
Results: Compared with NCI-H446 cells, the sphere formation rate, colony formation rate, and the expression of MnSOD and uPAR were significantly increased in the second passage sphere formation cells in NCI-H446 cells (P<0.05). Silence of MnSOD inhibited the sphere formation rate, colony formation rate, and the expression level of uPAR in the second passage sphere formation cells in NCI-H446 cells.
Conclusion: MnSOD may promote tumorigenicity in NCI-H446 cells by up-regulation of uPAR expression in vitro.
Adenoviridae
;
Carcinogenesis
;
Cell Line, Tumor
;
Humans
;
In Vitro Techniques
;
Lung Neoplasms
;
etiology
;
metabolism
;
RNA Interference
;
Receptors, Urokinase Plasminogen Activator
;
genetics
;
metabolism
;
Small Cell Lung Carcinoma
;
etiology
;
metabolism
;
Spheroids, Cellular
;
pathology
;
Superoxide Dismutase
;
genetics
;
metabolism
;
Tumor Stem Cell Assay
;
Up-Regulation